TNF and diabetic cardiomyopathy: In vivo study using the model of diabetic cardiomyopathy demonstrated that the inhibition of TNF-α can relieve left ventricle dysfunction by reducing myocardial inflammation and cardiac fibrosis mediated by TNF-α responses [7].